NEWS
2020.10.14
Rebirthel concluded the research collaboration agreement with Fujita Health University. – Joint development of the therapy for the novel coronavirus infection using universal killer T cells –
Rebirthel Co., Ltd. concluded an agreement to collaborate with Fujita Health University to deve...
NEWS
2020.10.1
Rebirthel concluded the research license agreement with Otsuka Pharmaceutical.
Rebirthel Co., Ltd. (hereafter Rebirthel) concluded the research license agreement with Otsuka ...